| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000029013 |
| Receipt No. | R000032956 |
| Official scientific title of the study | An observational study to evaluate usefulness of ultra-high resolution mapping for superior vena cava isolation |
| Date of disclosure of the study information | 2017/09/06 |
| Last modified on | 2017/09/05 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | An observational study to evaluate usefulness of ultra-high resolution mapping for superior vena cava isolation | |
| Title of the study (Brief title) | Ultra-high resolution mapping in SVC isolation | |
| Region |
|
|
| Condition | |||
| Condition | Atrial fibrillation | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate usefulness of of ultra-high resolution mapping for superior vena cava isolation |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | technical success of SVC isolation |
| Key secondary outcomes | electrophysiological findings of SVC assessed by ultra-high resolution mapping
complications during SVC isolation |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients who undergo catheter ablation of atrial fibrillation | |||
| Key exclusion criteria | patients with significant cardiac structure disease | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuaki Tanaka |
| Organization | Yokosuka Kyosai Hospital |
| Division name | Cardiovascular Center |
| Address | 1-16, Yonegahamadori, Yokosuka, Kanagawa |
| TEL | +81468222710 |
| yasuaki@mxk.mesh.ne.jp | |
| Public contact | |
| Name of contact person | Yasuaki Tanaka |
| Organization | Yokosuka Kyosai Hospital |
| Division name | Cardiovascular Center |
| Address | 1-16, Yonegahamadori, Yokosuka, Kanagawa |
| TEL | +81468222710 |
| Homepage URL | |
| yasuaki@mxk.mesh.ne.jp | |
| Sponsor | |
| Institute | Yokosuka Kyosai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Patients with atrial fibrillation who undergo high-resolution superior vena cava mapping during sinus rhythm after pulmonary vein isolation are enrolled. After the mapping, if initiation of atrial fibrillation from SVC is identified, SVC isolation is performed. We evaluate the outcome, the electrophysiological findings, and complications during SVC isolation. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032956 |